Role transition in ASCOT-BPLA trial

Atenolol decreased more than Amlodipine. Thiazide increased as Perindopril increased. The main opponent of perindopril in ASCOT seemed to be bendroflumethiazide.



ASCOT BPLA: Lancet 2005;366:895-906. PMID:16154016